The Food and Drug Administration announced the detection of a shocking case of fraud in the drug market; A violation in which an expensive drug was sold with an appearance similar to the original sample, but expert investigations showed that its contents had nothing to do with the real drug.
Dr. Saeed Mehrzadi, warning against the supply of counterfeit drugs in the virtual space and informal market, said: In the investigations conducted, the size, appearance and other characteristics of the vial were compared with the original sample and it was found that the vial in question belonged to another drug. After emptying, this vial was filled with distilled water and was sold instead of the original drug with the label of the desired drug.
Referring to the significant difference in the price of this drug in the official network and the open market, he said: the price of this drug in the official network and in government currency is about 90 million Tomans, while its purchase from the open market costs about 500 to 600 million Tomans.
The Director General of the Office of Inspection and Performance Management of the Food and Drug Organization emphasized the dangers of buying drugs from unauthorized sources and added: the appearance of a drug is not a sign of its authenticity, and even a vial with the original drug label may contain a completely different substance.
According to the announcement of the Food and Drug Organization, Mehrzadi warned at the end: buying medicine from the virtual space and informal market, in addition to causing heavy financial damage, can endanger the health of the patient and his loved ones; Therefore, the drug should be obtained from official and authorized channels.
